{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T15:25:32Z","timestamp":1778253932305,"version":"3.51.4"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81872061"],"award-info":[{"award-number":["81872061"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-03662-1","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T12:46:07Z","timestamp":1760705167000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Ubiquitin-specific protease 34 serves as a novel prognostic biomarker through correlating with immune responses and cell proliferation in acute myeloid leukemia"],"prefix":"10.1007","volume":"16","author":[{"given":"Zhihui","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cuijuan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,17]]},"reference":[{"key":"3662_CR1","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1056\/NEJMra1406184","volume":"373","author":"H Dohner","year":"2015","unstructured":"Dohner H, Weisdorf DJ, Bloomfield CD. Acute myeloid leukemia. N Engl J Med. 2015;373:1136\u201352.","journal-title":"N Engl J Med"},{"key":"3662_CR2","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.molmed.2020.10.001","volume":"27","author":"R Culp-Hill","year":"2021","unstructured":"Culp-Hill R, D\u2019Alessandro A, Pietras EM. Extinguishing the embers: targeting AML metabolism. Trends Mol Med. 2021;27:332\u201344.","journal-title":"Trends Mol Med"},{"key":"3662_CR3","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1056\/NEJMoa1516192","volume":"374","author":"E Papaemmanuil","year":"2016","unstructured":"Papaemmanuil E, Gerstung M, Bullinger L, Gaidzik VI, Paschka P, Roberts ND, Potter NE, Heuser M, Thol F, Bolli N, Gundem G, Van Loo P, Martincorena I, Ganly P, Mudie L, McLaren S, O\u2019Meara S, Raine K, Jones DR, Teague JW, Butler AP, Greaves MF, Ganser A, Dohner K, Schlenk RF, Dohner H, Campbell PJ. Genomic classification and prognosis in acute myeloid leukemia. N Engl J Med. 2016;374:2209\u201321.","journal-title":"N Engl J Med"},{"key":"3662_CR4","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1038\/nm.3739","volume":"20","author":"D Popovic","year":"2014","unstructured":"Popovic D, Vucic D, Dikic I. Ubiquitination in disease pathogenesis and treatment. Nat Med. 2014;20:1242\u201353.","journal-title":"Nat Med"},{"key":"3662_CR5","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.devcel.2009.04.001","volume":"16","author":"A Adhikari","year":"2009","unstructured":"Adhikari A, Chen ZJ. Diversity of Polyubiquitin chains. Dev Cell. 2009;16:485\u20136.","journal-title":"Dev Cell"},{"key":"3662_CR6","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nrd.2017.152","volume":"17","author":"JA Harrigan","year":"2018","unstructured":"Harrigan JA, Jacq X, Martin NM, Jackson SP. Deubiquitylating enzymes and drug discovery: emerging opportunities. Nat Rev Drug Discov. 2018;17:57\u201378.","journal-title":"Nat Rev Drug Discov"},{"key":"3662_CR7","doi-asserted-by":"crossref","unstructured":"Jin JO, Puranik N, Bui QT, Yadav D, Lee PC. The ubiquitin system: an emerging therapeutic target for lung cancer. Int J Mol Sci, 22 (2021).","DOI":"10.3390\/ijms22179629"},{"key":"3662_CR8","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1152\/physrev.00002.2013","volume":"93","author":"MJ Clague","year":"2013","unstructured":"Clague MJ, Barsukov I, Coulson JM, Liu H, Rigden DJ, Urbe S. Deubiquitylases from genes to organism. Physiol Rev. 2013;93:1289\u2013315.","journal-title":"Physiol Rev"},{"key":"3662_CR9","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/s41467-020-20259-0","volume":"12","author":"H Lei","year":"2021","unstructured":"Lei H, Xu HZ, Shan HZ, Liu M, Lu Y, Fang ZX, Jin J, Jing B, Xiao XH, Gao SM, Gao FH, Xia L, Yang L, Liu LG, Wang WW, Liu CX, Tong Y, Wu YZ, Zheng JK, Chen GQ, Zhou L, Wu YL. Targeting USP47 overcomes tyrosine kinase inhibitor resistance and eradicates leukemia stem\/progenitor cells in chronic myelogenous leukemia. Nat Commun. 2021;12:51.","journal-title":"Nat Commun"},{"key":"3662_CR10","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/s41375-020-0878-x","volume":"35","author":"M Cartel","year":"2021","unstructured":"Cartel M, Mouchel PL, Gotanegre M, David L, Bertoli S, Mansat-De Mas V, Besson A, Sarry JE, Manenti S, Didier C. Inhibition of ubiquitin-specific protease 7 sensitizes acute myeloid leukemia to chemotherapy. Leukemia. 2021;35:417\u201332.","journal-title":"Leukemia"},{"key":"3662_CR11","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1038\/s41416-020-0731-z","volume":"122","author":"J Yang","year":"2020","unstructured":"Yang J, Meng C, Weisberg E, Case A, Lamberto I, Magin RS, Adamia S, Wang J, Gray N, Liu S, Stone R, Sattler M, Buhrlage S, Griffin JD. Inhibition of the deubiquitinase USP10 induces degradation of SYK. Br J Cancer. 2020;122:1175\u201384.","journal-title":"Br J Cancer"},{"key":"3662_CR12","first-page":"41","volume":"12","author":"E Engel","year":"2014","unstructured":"Engel E, Viargues P, Mortier M, Taillebourg E, Coute Y, Thevenon D, Fauvarque MO. Identifying USPs regulating immune signals in drosophila: USP2 deubiquitinates Imd and promotes its degradation by interacting with the proteasome. Cell Commun Signal. 2014;12:41.","journal-title":"Cell Commun Signal"},{"key":"3662_CR13","doi-asserted-by":"publisher","first-page":"8572","DOI":"10.1093\/nar\/gkt622","volume":"41","author":"SM Sy","year":"2013","unstructured":"Sy SM, Jiang J, O WS, Deng Y, Huen MS. The ubiquitin specific protease USP34 promotes ubiquitin signaling at DNA double-strand breaks. Nucleic Acids Res. 2013;41:8572\u201380.","journal-title":"Nucleic Acids Res"},{"key":"3662_CR14","doi-asserted-by":"crossref","unstructured":"Guo YC, Wang MY, Zhang SW, Wu YS, Zhou CC, Zheng RX, Shao B, Wang Y, Xie L, Liu WQ, Sun NY, Jing JJ, Ye L, Chen QM, Yuan Q. Ubiquitin-specific protease USP34 controls osteogenic differentiation and bone formation by regulating BMP2 signaling. EMBO J, 37 (2018).","DOI":"10.15252\/embj.201899398"},{"key":"3662_CR15","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1002\/jbmr.4015","volume":"35","author":"Q Li","year":"2020","unstructured":"Li Q, Wang M, Xue H, Liu W, Guo Y, Xu R, Shao B, Yuan Q. Ubiquitin-Specific protease 34 inhibits osteoclast differentiation by regulating NF-kappaB signaling. J Bone Min Res. 2020;35:1597\u2013608.","journal-title":"J Bone Min Res"},{"key":"3662_CR16","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1478-811X-11-25","volume":"11","author":"K Poalas","year":"2013","unstructured":"Poalas K, Hatchi EM, Cordeiro N, Dubois SM, Leclair HM, Leveau C, Alexia C, Gavard J, Vazquez A, Bidere N. Negative regulation of NF-kappaB signaling in T lymphocytes by the ubiquitin-specific protease USP34. Cell Commun Signal. 2013;11:25.","journal-title":"Cell Commun Signal"},{"key":"3662_CR17","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1128\/MCB.01094-10","volume":"31","author":"TT Lui","year":"2011","unstructured":"Lui TT, Lacroix C, Ahmed SM, Goldenberg SJ, Leach CA, Daulat AM, Angers S. The ubiquitin-specific protease USP34 regulates Axin stability and Wnt\/beta-catenin signaling. Mol Cell Biol. 2011;31:2053\u201365.","journal-title":"Mol Cell Biol"},{"key":"3662_CR18","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.ejpn.2015.07.013","volume":"19","author":"A Mimouni-Bloch","year":"2015","unstructured":"Mimouni-Bloch A, Yeshaya J, Kahana S, Maya I, Basel-Vanagaite L. A de-novo interstitial microduplication involving 2p16.1-p15 and mirroring 2p16.1-p15 microdeletion syndrome: clinical and molecular analysis. Eur J Paediatr Neurol. 2015;19:711\u20135.","journal-title":"Eur J Paediatr Neurol"},{"key":"3662_CR19","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13048-015-0158-y","volume":"8","author":"S Zhao","year":"2015","unstructured":"Zhao S, Tian Y, Zhang W, Xing X, Li T, Liu H, Huang T, Ning Y, Zhao H, Chen ZJ. An association study between USP34 and polycystic ovary syndrome. J Ovarian Res. 2015;8:30.","journal-title":"J Ovarian Res"},{"key":"3662_CR20","first-page":"4543","volume":"18","author":"C Li","year":"2018","unstructured":"Li C, Huang L, Lu H, Wang W, Chen G, Gu Y, Zhou Q, Peng Z, Feng Z. Expression and clinical significance of ubiquitinspecificprocessing protease 34 in diffuse large Bcell lymphoma. Mol Med Rep. 2018;18:4543\u201354.","journal-title":"Mol Med Rep"},{"key":"3662_CR21","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1002\/gcc.22184","volume":"53","author":"A Kwiecinska","year":"2014","unstructured":"Kwiecinska A, Ichimura K, Berglund M, Dinets A, Sulaiman L, Collins VP, Larsson C, Porwit A, Lagercrantz SB. Amplification of 2p as a genomic marker for transformation in lymphoma. Genes Chromosomes Cancer. 2014;53:750\u201368.","journal-title":"Genes Chromosomes Cancer"},{"key":"3662_CR22","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1182\/blood-2013-12-540716","volume":"124","author":"T Herold","year":"2014","unstructured":"Herold T, Metzeler KH, Vosberg S, Hartmann L, Rollig C, Stolzel F, Schneider S, Hubmann M, Zellmeier E, Ksienzyk B, Jurinovic V, Pasalic Z, Kakadia PM, Dufour A, Graf A, Krebs S, Blum H, Sauerland MC, Buchner T, Berdel WE, Woermann BJ, Bornhauser M, Ehninger G, Mansmann U, Hiddemann W, Bohlander SK, Spiekermann K, Greif PA. Isolated trisomy 13 defines a homogeneous AML subgroup with high frequency of mutations in spliceosome genes and poor prognosis. Blood. 2014;124:1304\u201311.","journal-title":"Blood"},{"key":"3662_CR23","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1200\/JCO.2012.44.3184","volume":"31","author":"Z Li","year":"2013","unstructured":"Li Z, Herold T, He C, Valk PJ, Chen P, Jurinovic V, Mansmann U, Radmacher MD, Maharry KS, Sun M, Yang X, Huang H, Jiang X, Sauerland MC, Buchner T, Hiddemann W, Elkahloun A, Neilly MB, Zhang Y, Larson RA, Le Beau MM, Caligiuri MA, Dohner K, Bullinger L, Liu PP, Delwel R, Marcucci G, Lowenberg B, Bloomfield CD, Rowley JD, Bohlander SK, Chen J. Identification of a 24-gene prognostic signature that improves the European LeukemiaNet risk classification of acute myeloid leukemia: an international collaborative study. J Clin Oncol. 2013;31:1172\u201381.","journal-title":"J Clin Oncol"},{"key":"3662_CR24","doi-asserted-by":"publisher","first-page":"18411","DOI":"10.1038\/srep18411","volume":"5","author":"A Kuett","year":"2015","unstructured":"Kuett A, Rieger C, Perathoner D, Herold T, Wagner M, Sironi S, Sotlar K, Horny HP, Deniffel C, Drolle H, Fiegl M. IL-8 as mediator in the microenvironment-leukaemia network in acute myeloid leukaemia. Sci Rep. 2015;5:18411.","journal-title":"Sci Rep"},{"key":"3662_CR25","doi-asserted-by":"publisher","first-page":"W98","DOI":"10.1093\/nar\/gkx247","volume":"45","author":"Z Tang","year":"2017","unstructured":"Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45:W98\u2013102.","journal-title":"Nucleic Acids Res"},{"key":"3662_CR26","doi-asserted-by":"publisher","first-page":"e238","DOI":"10.1002\/imt2.238","volume":"3","author":"D Chen","year":"2024","unstructured":"Chen D, Xu L, Xing H, Shen W, Song Z, Li H, Zhu X, Li X, Wu L, Jiao H, Li S, Yan J, He Y. Sangerbox 2: enhanced functionalities and update for a comprehensive clinical bioinformatics data analysis platform. Imeta. 2024;3:e238.","journal-title":"Imeta"},{"key":"3662_CR27","doi-asserted-by":"publisher","first-page":"D881","DOI":"10.1093\/nar\/gky1076","volume":"47","author":"FO Bagger","year":"2019","unstructured":"Bagger FO, Kinalis S, Rapin N. BloodSpot: a database of healthy and malignant haematopoiesis updated with purified and single cell mRNA sequencing profiles. Nucleic Acids Res. 2019;47:D881\u20135.","journal-title":"Nucleic Acids Res"},{"key":"3662_CR28","doi-asserted-by":"publisher","first-page":"4797","DOI":"10.1182\/blood-2007-09-113027","volume":"111","author":"MH Tomasson","year":"2008","unstructured":"Tomasson MH, Xiang Z, Walgren R, Zhao Y, Kasai Y, Miner T, Ries RE, Lubman O, Fremont DH, McLellan MD, Payton JE, Westervelt P, DiPersio JF, Link DC, Walter MJ, Graubert TA, Watson M, Baty J, Heath S, Shannon WD, Nagarajan R, Bloomfield CD, Mardis ER, Wilson RK, Ley TJ. Somatic mutations and germline sequence variants in the expressed tyrosine kinase genes of patients with de Novo acute myeloid leukemia. Blood. 2008;111:4797\u2013808.","journal-title":"Blood"},{"key":"3662_CR29","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102:15545\u201350.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3662_CR30","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman AM, Liu CL, Green MR, Gentles AJ, Feng W, Xu Y, Hoang CD, Diehn M, Alizadeh AA. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12:453\u20137.","journal-title":"Nat Methods"},{"key":"3662_CR31","doi-asserted-by":"crossref","unstructured":"Thorsson V, Gibbs DL, Brown SD, Wolf D, Bortone DS, Ou Yang TH, Porta-Pardo E, Gao GF, Plaisier CL, Eddy JA, Ziv E, Culhane AC, Paull EO, Sivakumar IKA, Gentles AJ, Malhotra R, Farshidfar F, Colaprico A, Parker JS, Mose LE, Vo NS, Liu J, Liu Y, Rader J, Dhankani V, Reynolds SM, Bowlby R, Califano A, Cherniack AD, Anastassiou D, Bedognetti D, Mokrab Y, Newman AM, Rao A, Chen K, Krasnitz A, Hu H, Malta TM, Noushmehr H, Pedamallu CS, Bullman S, Ojesina AI, Lamb A, Zhou W, Shen H, Choueiri TK, Weinstein JN, Guinney J, Saltz J, Holt RA, Rabkin CS, N., Lazar AJ, Serody JS, Demicco EG, Disis ML. B.G. Vincent, I. Shmulevich, The Immune Landscape of Cancer, Immunity, 48 (2018) 812\u2013e830814.","DOI":"10.1016\/j.immuni.2018.03.023"},{"key":"3662_CR32","doi-asserted-by":"publisher","first-page":"1902880","DOI":"10.1002\/advs.201902880","volume":"7","author":"YR Miao","year":"2020","unstructured":"Miao YR, Zhang Q, Lei Q, Luo M, Xie GY, Wang H, Guo AY. ImmuCellAI: A unique method for comprehensive T-Cell subsets abundance prediction and its application in cancer immunotherapy. Adv Sci (Weinh). 2020;7:1902880.","journal-title":"Adv Sci (Weinh)"},{"key":"3662_CR33","doi-asserted-by":"publisher","first-page":"213","DOI":"10.3389\/fonc.2018.00213","volume":"8","author":"AJ Lamble","year":"2018","unstructured":"Lamble AJ, Lind EF. Targeting the immune microenvironment in acute myeloid leukemia: A focus on T cell immunity. Front Oncol. 2018;8:213.","journal-title":"Front Oncol"},{"key":"3662_CR34","doi-asserted-by":"crossref","unstructured":"Sendker S, Reinhardt D, Niktoreh N. Redirecting the immune microenvironment in acute myeloid leukemia. Cancers (Basel), 13 (2021).","DOI":"10.3390\/cancers13061423"},{"key":"3662_CR35","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.1038\/onc.2011.443","volume":"31","author":"JM Fraile","year":"2012","unstructured":"Fraile JM, Quesada V, Rodriguez D, Freije JM. Lopez-Otin, deubiquitinases in cancer: new functions and therapeutic options. Oncogene. 2012;31:2373\u201388.","journal-title":"Oncogene"},{"key":"3662_CR36","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1038\/nm.2536","volume":"17","author":"P D\u2019Arcy","year":"2011","unstructured":"D\u2019Arcy P, Brnjic S, Olofsson MH, Fryknas M, Lindsten K, De Cesare M, Perego P, Sadeghi B, Hassan M, Larsson R, Linder S. Inhibition of proteasome deubiquitinating activity as a new cancer therapy. Nat Med. 2011;17:1636\u201340.","journal-title":"Nat Med"},{"key":"3662_CR37","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1080\/19768354.2019.1661283","volume":"23","author":"YC Chae","year":"2019","unstructured":"Chae YC, Jung H, Kim JY, Lee DH, Seo SB. Ubiquitin-specific peptidase 3 induces TPA-mediated leukemia cell differentiation via regulating H2AK119ub. Anim Cells Syst (Seoul). 2019;23:311\u20137.","journal-title":"Anim Cells Syst (Seoul)"},{"key":"3662_CR38","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1038\/nchembio.2486","volume":"13","author":"EL Weisberg","year":"2017","unstructured":"Weisberg EL, Schauer NJ, Yang J, Lamberto I, Doherty L, Bhatt S, Nonami A, Meng C, Letai A, Wright R, Tiv H, Gokhale PC, Ritorto MS, De Cesare V, Trost M, Christodoulou A, Christie A, Weinstock DM, Adamia S, Stone R, Chauhan D, Anderson KC, Seo HS, Dhe-Paganon S, Sattler M, Gray NS, Griffin JD, Buhrlage SJ. Inhibition of USP10 induces degradation of oncogenic FLT3. Nat Chem Biol. 2017;13:1207\u201315.","journal-title":"Nat Chem Biol"},{"key":"3662_CR39","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/s41375-021-01394-z","volume":"36","author":"M Niederkorn","year":"2022","unstructured":"Niederkorn M, Ishikawa C, K MH, Bartram J, Stepanchick E, J RB, A EC-C, Bolanos LC, Uible E, Choi K, Wunderlich M, Perentesis JP, T MC, Filippi MD, Starczynowski DT. The deubiquitinase USP15 modulates cellular redox and is a therapeutic target in acute myeloid leukemia. Leukemia. 2022;36:438\u201351.","journal-title":"Leukemia"},{"key":"3662_CR40","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1182\/blood-2017-10-811760","volume":"132","author":"J Melo-Cardenas","year":"2018","unstructured":"Melo-Cardenas J, Xu Y, Wei J, Tan C, Kong S, Gao B, Montauti E, Kirsammer G, Licht JD, Yu J, Ji P, Crispino JD, Fang D. USP22 deficiency leads to myeloid leukemia upon oncogenic Kras activation through a PU.1-dependent mechanism. Blood. 2018;132:423\u201334.","journal-title":"Blood"},{"key":"3662_CR41","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1172\/JCI129204","volume":"130","author":"L Vago","year":"2020","unstructured":"Vago L, Gojo I. Immune escape and immunotherapy of acute myeloid leukemia. J Clin Invest. 2020;130:1552\u201364.","journal-title":"J Clin Invest"},{"key":"3662_CR42","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.critrevonc.2016.04.020","volume":"103","author":"R Austin","year":"2016","unstructured":"Austin R, Smyth MJ, Lane SW. Harnessing the immune system in acute myeloid leukaemia. Crit Rev Oncol Hematol. 2016;103:62\u201377.","journal-title":"Crit Rev Oncol Hematol"},{"key":"3662_CR43","doi-asserted-by":"publisher","first-page":"3909","DOI":"10.1182\/blood-2009-02-206946","volume":"114","author":"R Le Dieu","year":"2009","unstructured":"Le Dieu R, Taussig DC, Ramsay AG, Mitter R, Miraki-Moud F, Fatah R, Lee AM, Lister TA, Gribben JG. Peripheral blood T cells in acute myeloid leukemia (AML) patients at diagnosis have abnormal phenotype and genotype and form defective immune synapses with AML blasts. Blood. 2009;114:3909\u201316.","journal-title":"Blood"},{"key":"3662_CR44","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3389\/fimmu.2017.00064","volume":"8","author":"J Rey","year":"2017","unstructured":"Rey J, Fauriat C, Kochbati E, Orlanducci F, Charbonnier A, D\u2019Incan E, Andre P, Romagne F, Barbarat B, Vey N, Olive D. Kinetics of cytotoxic lymphocytes reconstitution after induction chemotherapy in elderly AML patients reveals progressive recovery of normal phenotypic and functional features in NK cells. Front Immunol. 2017;8:64.","journal-title":"Front Immunol"},{"key":"3662_CR45","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/1471-2172-11-38","volume":"11","author":"E Ersvaer","year":"2010","unstructured":"Ersvaer E, Liseth K, Skavland J, Gjertsen BT, Bruserud O. Intensive chemotherapy for acute myeloid leukemia differentially affects Circulating TC1, TH1, TH17 and TREG cells. BMC Immunol. 2010;11:38.","journal-title":"BMC Immunol"},{"key":"3662_CR46","doi-asserted-by":"publisher","first-page":"3325","DOI":"10.1158\/1078-0432.CCR-08-3010","volume":"15","author":"MJ Szczepanski","year":"2009","unstructured":"Szczepanski MJ, Szajnik M, Czystowska M, Mandapathil M, Strauss L, Welsh A, Foon KA, Whiteside TL, Boyiadzis M. Increased frequency and suppression by regulatory T cells in patients with acute myelogenous leukemia. Clin Cancer Res. 2009;15:3325\u201332.","journal-title":"Clin Cancer Res"},{"key":"3662_CR47","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1111\/j.1600-0609.2005.00537.x","volume":"75","author":"X Wang","year":"2005","unstructured":"Wang X, Zheng J, Liu J, Yao J, He Y, Li X, Yu J, Yang J, Liu Z, Huang S. Increased population of CD4(+)CD25(high), regulatory T cells with their higher apoptotic and proliferating status in peripheral blood of acute myeloid leukemia patients. Eur J Haematol. 2005;75:468\u201376.","journal-title":"Eur J Haematol"},{"key":"3662_CR48","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/j.cell.2019.01.031","volume":"176","author":"P van Galen","year":"2019","unstructured":"van Galen P, Hovestadt V, Wadsworth MH II, Hughes T.K., Griffin G.K., Battaglia S, Verga JA, Stephansky J, Pastika TJ, Lombardi Story J, Pinkus GS, Pozdnyakova O, Galinsky I, Stone RM, Graubert T.A., Shalek A.K., Aster J.C., Lane A.A., Bernstein B.E. Single-Cell RNA-Seq reveals AML hierarchies relevant to disease progression and immunity. Cell. 2019;176:1265\u201381. e1224.","journal-title":"Cell"},{"key":"3662_CR49","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s10555-011-9270-7","volume":"30","author":"B Mlecnik","year":"2011","unstructured":"Mlecnik B, Bindea G, Pages F, Galon J. Tumor immunosurveillance in human cancers. Cancer Metastasis Rev. 2011;30:5\u201312.","journal-title":"Cancer Metastasis Rev"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03662-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-03662-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03662-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T13:03:46Z","timestamp":1760706226000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-03662-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,17]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3662"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-03662-1","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,17]]},"assertion":[{"value":"11 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study utilizes open-access databases and does not engage in original research involving human participants or animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1914"}}